ES519005A0 - Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas. - Google Patents

Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas.

Info

Publication number
ES519005A0
ES519005A0 ES519005A ES519005A ES519005A0 ES 519005 A0 ES519005 A0 ES 519005A0 ES 519005 A ES519005 A ES 519005A ES 519005 A ES519005 A ES 519005A ES 519005 A0 ES519005 A0 ES 519005A0
Authority
ES
Spain
Prior art keywords
quinazolinones
tetrazole
preparing
procedure
tetrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519005A
Other languages
English (en)
Spanish (es)
Other versions
ES8501758A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of ES8501758A1 publication Critical patent/ES8501758A1/es
Publication of ES519005A0 publication Critical patent/ES519005A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Materials For Photolithography (AREA)
ES519005A 1982-01-18 1983-01-14 Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas. Granted ES519005A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/340,577 US4419357A (en) 1982-01-18 1982-01-18 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Publications (2)

Publication Number Publication Date
ES8501758A1 ES8501758A1 (es) 1984-12-16
ES519005A0 true ES519005A0 (es) 1984-12-16

Family

ID=23333997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519005A Granted ES519005A0 (es) 1982-01-18 1983-01-14 Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas.

Country Status (18)

Country Link
US (1) US4419357A (en])
EP (1) EP0086340B1 (en])
JP (1) JPS58124783A (en])
KR (1) KR880002358B1 (en])
AT (1) ATE18908T1 (en])
AU (2) AU555629B2 (en])
CA (1) CA1254204A (en])
DE (1) DE3362735D1 (en])
DK (1) DK159271C (en])
ES (1) ES519005A0 (en])
GB (2) GB2113220B (en])
GR (1) GR77393B (en])
IE (1) IE54441B1 (en])
IL (1) IL67686A (en])
NO (1) NO830115L (en])
NZ (1) NZ203034A (en])
PH (1) PH18222A (en])
ZA (1) ZA83240B (en])

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4644065A (en) 1984-05-15 1987-02-17 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 4(3H)-quinazolinones
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
US4761474A (en) * 1986-02-25 1988-08-02 Merrell Dow Pharmaceuticals Inc. 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
US4757075A (en) * 1986-10-14 1988-07-12 Merrell Dow Pharmaceuticals Inc. Tetrazolylquinazolinones as anti-hyperuricemic agents
US8975288B2 (en) 2012-04-10 2015-03-10 The Penn State Research Foundation F2 derivatives as antibacterial agents
AU2013206392B2 (en) * 2012-04-27 2016-05-12 Basf Se Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364040A (fr) * 1960-04-19 1962-08-31 Ipa Anstalt Dispositif de détection pour vérifier si un élément d'une installation électrique est sous tension
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
IT1050750B (it) 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
AU508970B2 (en) * 1976-02-13 1980-04-17 Bristol-Myers Company Tetrazole derivatives
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Also Published As

Publication number Publication date
GB2170800A (en) 1986-08-13
KR880002358B1 (ko) 1988-10-29
GB2113220B (en) 1985-09-04
US4419357A (en) 1983-12-06
EP0086340A1 (en) 1983-08-24
GB8428402D0 (en) 1984-12-19
NZ203034A (en) 1985-09-13
DK16783A (da) 1983-07-19
AU6151786A (en) 1986-12-11
GB8300957D0 (en) 1983-02-16
DE3362735D1 (de) 1986-05-07
CA1254204A (en) 1989-05-16
AU570852B2 (en) 1988-03-24
ATE18908T1 (de) 1986-04-15
DK159271B (da) 1990-09-24
EP0086340B1 (en) 1986-04-02
DK16783D0 (da) 1983-01-17
ZA83240B (en) 1983-10-26
IL67686A0 (en) 1983-05-15
GB2113220A (en) 1983-08-03
IL67686A (en) 1985-12-31
PH18222A (en) 1985-04-30
IE54441B1 (en) 1989-10-11
JPH0450310B2 (en]) 1992-08-13
GR77393B (en]) 1984-09-11
ES8501758A1 (es) 1984-12-16
IE830078L (en) 1983-07-18
AU555629B2 (en) 1986-10-02
GB2170800B (en) 1987-01-07
DK159271C (da) 1991-02-18
JPS58124783A (ja) 1983-07-25
AU1037783A (en) 1983-07-28
NO830115L (no) 1983-07-19
KR840003250A (ko) 1984-08-20

Similar Documents

Publication Publication Date Title
ES519005A0 (es) Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas.
ES538576A0 (es) Procedimiento para la obtencion de derivados de arilamina
ES2053686T3 (es) Nuevos di(met)acrilatos, procedimiento para su fabricacion y su empleo.
ES534532A0 (es) Un procedimiento para preparar derivados de benzamida.
SE8402361D0 (sv) Novel acylaminophenol derivatives
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
DE3468683D1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide
IL71987A (en) N-(beta-fluoroethyl)nortropine,its preparation and use in preparation of the corresponding 3-alpha-benzilate
ES544712A0 (es) Procedimiento para la obtencion de iminosulfonamidas
ES539117A0 (es) Procedimiento para la preparacion de compuestos de pirazina-bis(2-oxoglicina)antialergico.
AR214598A1 (es) Aparato para el armado,montaje y ajuste de los llamados"silent blocks"
ES243240Y (es) Dispositivo grapador para el armado de marcos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519